StonvexLoading…
StonvexStonvexStonvexCore line items from INVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.41M | $21.48M | $15.32M | $10.31M |
Operating Income | $-4.20M | $-22.15M | $-17.44M | $-11.86M |
Net Income | $-3.45M | $-18.00M | $-14.28M | $-10.83M |
EPS (Diluted) | $-0.15 | $-0.79 | $-0.63 | $-0.47 |
Total Assets | $147.63M | $151.34M | $151.02M | $153.88M |
Total Liabilities | $10.48M | $10.64M | $7.36M | $7.46M |
Cash & Equivalents | $124.53M | $128.61M | $126.27M | $129.34M |
Free Cash Flow OCF − CapEx | $-3.72M | $-7.81M | $-10.63M | $-7.40M |
Shares Outstanding | 23.95M | 23.77M | 23.73M | 23.66M |